Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00246_DB01599_nanopub.RA5BrSrX0oNKmPo16K9MA5FDlltW4NjwsauRJQDp0B_TA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00246_DB01599 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00246_DB01599 label "DDI between Ziprasidone and Probucol - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated. [drugbank_resource:DB00246_DB01599]" assertion.
- drugbank_resource:DB00246_DB01599 identifier "drugbank_resource:DB00246_DB01599" assertion.
- drugbank_resource:DB00246_DB01599 title "DDI between Ziprasidone and Probucol - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00246 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00246_DB01599 assertion.
- drugbank:DB01599 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00246_DB01599 assertion.